Eiken Chemical: Announcement of the new release of the automatic urine analyzer “US-1300”
Eiken Chemical: change report
Eiken Chemical: Half Year Report - Term 87 (2024/04/01 - 2025/03/31)
Eiken Chemical: Confirmation letter
Eiken Chemical: Notice of obtaining approval for manufacture and sale of the “Gene Analysis Program MinTS Analyzer” and “MinTS Lung Cancer Multi CDx Library Preparation Reagent Kit”
Eiken Chemical: Comprehensive partnership agreement concluded with Tokyo University of Science
Eiken Chemical: Notice regarding investment in Nanotis to develop digital testing technology for infectious diseases caused by saliva
Eiken Chemical: Notice Concerning Decisions on Matters Relating to the Acquisition of Treasury Shares
Eiken Chemical: Financial results briefing materials for the 2nd quarter (interim period) of the fiscal year ending 2025/3
Eiken Chemical: Notice regarding differences from the consolidated cumulative period earnings forecast for the 2nd quarter (interim period) and revisions to the full-year consolidated earnings forecast
Eiken Chemical: Summary of financial results for the 2nd quarter (interim period) of the fiscal year ending 2025/3 [Japanese GAAP] (Consolidated)
Eiken Chemical: Change report.
Eiken Chemical: Change Report
Mass holding report (stock certificates subject to special cases, etc.)
Eiken Chemical: Eiken Chemical Integrated Report 2024
Eiken Chemical: Announcement of the release of the integrated report “Eiken Chemical Integrated Report 2024”
Eiken Chemical: Change report.
Eiken Chemical: Announcements of individual stocks regarding the collaboration between Hitachi High-Tech Corporation and Tosoh Corporation in promoting the sales of biochemistry and immune transport systems.
Eiken Chemical: Change report.
Eiken Chemical: Change Report
No Data
No Data